Ardekani Leila Ghaderi
Papers
1
Total Citations
21
H-Index
1
About
Dr. Leila Ghaderi Ardekani is a leading researcher in the field of radiation oncology, with a primary focus on motion management and treatment accuracy in stereotactic body radiotherapy (SBRT). Her most notable contribution is the development and validation of active motion-compensated techniques for liver SBRT, as demonstrated in her highly cited 2019 study, which has garnered 21 citations. In this work, she pioneered a novel method for analyzing in-vivo treatment accuracy by registering planned radiation doses with post-therapeutic MRI-morphologic alterations, enabling precise assessment of how well the delivered dose matches the intended target in moving organs. This breakthrough directly addresses one of the most challenging aspects of liver radiotherapy—respiratory-induced tumor motion—and provides a robust framework for improving treatment outcomes. Dr. Ardekani's research has significant clinical implications, offering a pathway to reduce toxicity and enhance tumor control in patients with liver malignancies. Her work bridges the gap between advanced imaging and radiation delivery, making her a key figure in the evolution of personalized, adaptive radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1